All Articles

Lōkahi Therapeutics aims to turn 15 injections into one for its pain drug LT-100, a move that could transform patient care and unlock major commercial value.

China's heavy machinery giant opens its first overseas EV plant in Indonesia, a strategic move reshaping global supply chains and testing the limits of green industrialization.

The Missouri lender posts a 20% jump in Q2 net income, but declining loans and deposits, plus rising non-performing assets, reveal a complex picture.

USLM posts strong Q2 earnings by riding a wave of industrial demand, navigating high costs, and betting on the data center boom to offset a weak housing market.

Latigo Biotherapeutics' new drug LTG-001 shows superior, faster pain relief than Vicodin in a major trial, offering a potent new tool against the opioid crisis.

With a massive $113M Series B, Onyx Security is tackling enterprise AI's biggest risk: unaccountable agents. It's a bet on a new security category.

Cactus Inc. crushed Q2 estimates and boosted its dividend by 7%, signaling deep confidence. A closer look reveals how its Spoolable Tech and strategic global expansion are creating a resilient growth engine.

Kinross Gold unveils robust economics for its Chilean mega-project, balancing a massive valuation with a modern focus on sustainability and regional partnership.

As Asian traders navigate a sea of online noise, Mitrade’s partnership with Bloomberg signals a significant flight to quality and a savvy move for brand credibility.

A Dutch court dismissed Shell’s €1B claim against Clariant, a key win. Yet, with billions more in lawsuits pending, is this a true signal of strength?

Hawthorn's steady dividend is a beacon for income investors, but a deeper dive reveals a story of strategic capital management and regional banking resilience.

Sunwest Bank completes a strategic acquisition of Colorado branches, challenging the regional banking landscape with its unique blend of high-tech and high-touch service.

Anterix's upcoming earnings report isn't just for investors. It's a crucial look at the hidden infrastructure powering our AI, EV, and climate-resilient future.

Nebraska's Central Plains Bancshares plans a major stock buyback, signaling confidence. But with an activist investor pushing, is this a bold strategy or a forced hand?

Alerus reports strong Q2 earnings, driven by a resilient diversified model and a dramatic 68% reduction in nonperforming assets, boosting shareholder returns.

R. Stanton Dodge, a veteran of DraftKings and DISH, is National Jewish Health's new chair. His corporate playbook may be exactly what medicine needs.

Smartcat's new AI tool promises to keep global learning content current across all languages, aiming to turn a major compliance risk into a strength.

A return to profitability, fueled by asset sales, coincides with a major strategic review, placing the offshore services firm at a pivotal crossroads.

Despite a narrow net loss, CVR Energy’s Q2 results reveal a powerful strategy. High utilization in both oil and fertilizer shows how diversification thrives in a volatile world.

Everest Group's Q2 shows lower income but a 'strong' quarter. Behind the numbers is a strategic pivot to underwriting discipline and aggressive buybacks.